Produktname:2-nitro-5,6,8,9-tetrahydro-7H-benzo[7]annulen-7-one

IUPAC Name:2-nitro-6,7,8,9-tetrahydro-5H-benzo[7]annulen-7-one

CAS:740842-50-6
Molekulare Formel:C11H11NO3
Reinheit:95%
Katalognummer:CM153725
Molekulargewicht:205.21

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM153725-1g 1-2 Weeks Ÿœƚ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:740842-50-6
Molekulare Formel:C11H11NO3
Schmelzpunkt:-
SMILES-Code:O=C1CCC2=CC([N+]([O-])=O)=CC=C2CC1
Dichte:
Katalognummer:CM153725
Molekulargewicht:205.21
Siedepunkt:
Mdl-Nr.:MFCD11869793
Lagerung:Store at room temperature.

Column Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products